NCT06105528View on ClinicalTrials.gov

A Phase 1a Study of PMN310 In Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

November 18, 2023

Primary Completion Date

July 31, 2024

Study Completion Date

July 31, 2024

Conditions
Healthy Participants
Interventions
DRUG

PMN310

60-minute intravenous infusion

DRUG

Placebo

60-minute intravenous infusion

Trial Locations (2)

33014

Clinical Pharmacology of Miami, LLC, Miami

43212

Ohio Clinical Trials, Columbus

Sponsors
All Listed Sponsors
lead

ProMis Neurosciences, Inc

INDUSTRY

NCT06105528 - A Phase 1a Study of PMN310 In Healthy Volunteers | Biotech Hunter | Biotech Hunter